FDA ApprovedUnited States
First FDA-Approved Treatment for Alexander Disease
Zanvastro (zilganersen) for Alexander disease (AxD)
The first FDA-labelled medicine for Alexander disease — an ultra-rare, progressive GFAP leukodystrophy.
Zanvastro (zilganersen) is the first approved medicine for Alexander disease, a very rare brain disease.